Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Sestrin2 is a leucine sensor for the mTORC1 pathway

Sestrin2 is a leucine sensor for the mTORC1 pathway

Thumbnail Image
Download
Name

Sabatini_Sestrin2 is a leucine.pdf

Size

1.42 MB

Format

Adobe PDF

Checksum (MD5)

7e4dedb4c74405535c951cce6e6bfeb5

Author(s)
Shen, K.
•
Cantor, J. R.
•
Wolfson, Rachel Laura
•
Chantranupong, Lynne
•
Saxton, Robert Andrew
•
Scaria, Sonia M.
•
Sabatini, David
Date Issued
January 2016
Journal
Science
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Wolfson, R. L., L. Chantranupong, R. A. Saxton, K. Shen, S. M. Scaria, J. R. Cantor, and D. M. Sabatini. “Sestrin2 Is a Leucine Sensor for the mTORC1 Pathway.” Science 351, no. 6268 (October 8, 2015): 43–48. © 2016 American Association for the Advancement of Science
Version
Author's final manuscript
Abstract
Leucine is a proteogenic amino acid that also regulates many aspects of mammalian physiology, in large part by activating the mTOR complex 1 (mTORC1) protein kinase, a master growth controller. Amino acids signal to mTORC1 through the Rag guanosine triphosphatases (GTPases). Several factors regulate the Rags, including GATOR1, aGTPase-activating protein; GATOR2, a positive regulator of unknown function; and Sestrin2, a GATOR2-interacting protein that inhibits mTORC1 signaling. We find that leucine, but not arginine, disrupts the Sestrin2-GATOR2 interaction by binding to Sestrin2 with a dissociation constant of 20 micromolar, which is the leucine concentration that half-maximally activates mTORC1. The leucine-binding capacity of Sestrin2 is required for leucine to activate mTORC1 in cells. These results indicate that Sestrin2 is a leucine sensor for the mTORC1 pathway.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/107960
DOI of Published Version
https://doi.org/10.1126/science.aab2674
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.